| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cue Biopharma, Inc. | Director | Common Stock | 323,857 | $97,675 | $0.3016 | 30 Dec 2025 | Direct |
| Cue Biopharma, Inc. | Director | Stock Option (right to buy) | 24,400 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Director | 06 Jan 2026, 16:00 |
| CUE | Cue Biopharma, Inc. | 30 Dec 2025 | 5 | +$99,747 | 4 | Director | 02 Jan 2026, 16:00 |
| CUE | Cue Biopharma, Inc. | 10 Mar 2025 | 1 | $0 | 4 | Director | 12 Mar 2025, 16:00 |
| CUE | Cue Biopharma, Inc. | 10 Mar 2025 | 0 | $0 | 3 | Director | 12 Mar 2025, 16:00 |